Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Farmaceutleasing i Syd Aktiebolag
AB
Dissolved
Org 5592071251
Retail sale of pharmaceutical products
· NACE 4773
Est. 2019
1 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
Farmaceutleasing i Syd Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2019
1M
2020
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2019
0M
2020
Income statement
SEK thousands
Item
2019
2020
Revenue
339
587
Staff expenses
—
—
EBITDA
5
75
Depreciation & amort.
−0
−0
EBIT
5
75
Net financials
—
—
Profit before tax
5
75
Tax
−1
−16
Net profit
4
59
Balance sheet
SEK thousands
Item
2019
2020
Total assets
225
149
Equity
54
113
Long-term debt
0
0
Short-term debt
170
36
Total debt
170
36
Financial ratios
5-year trend
EBITDA margin
12.8%
This company
15.8%
Market median
-19% vs market
2019
2020
Equity ratio
75.8%
This company
38.2%
Market median
+98% vs market
2019
2020
Return on equity
52.2%
This company
18.4%
Market median
+184% vs market
2019
2020
Net profit margin
10.1%
This company
8.1%
Market median
+25% vs market
2019
2020
Asset turnover
3.94×
This company
1.12×
Market median
+252% vs market
2019
2020
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
2019
2020
Annual reports & filings
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
Annual report 2019
Filed via Bolagsverket / SCB · Period 2019-05-01 – 2019-12-31
View
PDF
More on Farmaceutleasing i Syd Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot